Savaria Co. (TSE:SIS – Get Free Report) Director Marcel Bourassa sold 7,500 shares of the business’s stock in a transaction on Tuesday, June 16th. The shares were sold at an average price of C$29.53, for a total transaction of C$221,475.00. Following the sale, the director directly owned 225,431 shares of the company’s stock, valued at approximately C$6,656,977.43. The trade was a 3.22% decrease in their position.
Savaria Trading Down 1.5%
TSE:SIS opened at C$28.46 on Tuesday. Savaria Co. has a one year low of C$18.84 and a one year high of C$30.62. The business has a fifty day moving average price of C$28.94 and a 200-day moving average price of C$26.11. The firm has a market capitalization of C$2.05 billion, a price-to-earnings ratio of 25.87, a price-to-earnings-growth ratio of 42.72 and a beta of 1.06. The company has a debt-to-equity ratio of 31.42, a current ratio of 1.71 and a quick ratio of 0.91.
Savaria (TSE:SIS – Get Free Report) last released its earnings results on Wednesday, May 6th. The company reported C$0.31 earnings per share for the quarter. The company had revenue of C$235.54 million for the quarter. Savaria had a return on equity of 12.41% and a net margin of 8.50%. Sell-side analysts forecast that Savaria Co. will post 1.2048518 EPS for the current year.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on Savaria
About Savaria
Savaria Corporation ( savaria.com ) is a global leader in the accessibility industry. It provides accessibility solutions for the physically challenged to increase their comfort, their mobility and their independence. Its product line is one of the most comprehensive on the market. Savaria designs, manufactures, distributes and installs accessibility equipment, such as stairlifts for straight and curved stairs, vertical and inclined wheelchair lifts and elevators for home and commercial use. It also manufactures and markets a comprehensive selection of pressure management products for the medical market, medical beds for the long-term care market, as well as an extensive line of medical equipment and solutions for the safe handling of patients, including ceiling lifts and slings.
Featured Stories
- Five stocks we like better than Savaria
- Buy CrowdStrike Before the Stock Split? Here’s the Case
- Investors Are Buying Into Sweetgreen Again—Should They?
- Burlington Is Winning Over Shoppers But Investors Need Patience
- USA Today’s Digital Revival Is Gaining Steam, But With Plenty of Risk
Receive News & Ratings for Savaria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Savaria and related companies with MarketBeat.com's FREE daily email newsletter.
